[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kim et al., 2017 - Google Patents

Structure-dependent antimicrobial theranostic functions of self-assembled short peptide nanoagents

Kim et al., 2017

Document ID
17580981004188694361
Author
Kim I
Jin S
Han E
Ko E
Ahn M
Bang W
Bang J
Lee E
Publication year
Publication venue
Biomacromolecules

External Links

Snippet

Gadolinium (Gd [III])-based nanoaggregates are potential noninvasive magnetic resonance imaging (MRI) probes with excellent spatial and temporal resolution for cancer diagnosis. Peptides conjugated with Gd3+ can aid in supramolecular scaffolding for MRI nanoagents …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Ghosh et al. pH-responsive biocompatible supramolecular peptide hydrogel
Zhou et al. Molecularly stimuli-responsive self-assembled peptide nanoparticles for targeted imaging and therapy
Sapra et al. Designer peptide and protein dendrimers: a cross-sectional analysis
Lock et al. One-component supramolecular filament hydrogels as theranostic label-free magnetic resonance imaging agents
Rad-Malekshahi et al. Biomedical applications of self-assembling peptides
Toft et al. Coassembled cytotoxic and pegylated peptide amphiphiles form filamentous nanostructures with potent antitumor activity in models of breast cancer
Aluri et al. Elastin-like peptide amphiphiles form nanofibers with tunable length
Zhang et al. Cellular uptake and cytotoxicity of drug–peptide conjugates regulated by conjugation site
Sanchez-Navarro et al. Jumping hurdles: Peptides able to overcome biological barriers
Suma et al. Modulated fragmentation of proapoptotic peptide nanoparticles regulates cytotoxicity
Tarvirdipour et al. Peptide-based nanoassemblies in gene therapy and diagnosis: paving the way for clinical application
Fukushima et al. Broad-spectrum antimicrobial supramolecular assemblies with distinctive size and shape
Kim et al. Structure-dependent antimicrobial theranostic functions of self-assembled short peptide nanoagents
Xu et al. Fabrication and microscopic and spectroscopic characterization of cytocompatible self-assembling antimicrobial nanofibers
Kim et al. One-dimensional supramolecular nanoplatforms for theranostics based on co-assembly of peptide amphiphiles
Sigg et al. Stimuli-responsive codelivery of oligonucleotides and drugs by self-assembled peptide nanoparticles
Hamley et al. Self-assembly of peptide bioconjugates: selected recent research highlights
Li et al. Self-assembly of amphiphilic peptides for recognizing high furin-expressing cancer cells
Qin et al. Self-assembly of stable nanoscale platelets from designed elastin-like peptide–collagen-like peptide bioconjugates
Missirlis et al. Mechanisms of peptide amphiphile internalization by SJSA-1 cells in vitro
Gong et al. Plasma amine oxidase-induced nanoparticle-to-nanofiber geometric transformation of an amphiphilic peptide for drug encapsulation and enhanced bactericidal activity
Li et al. Design of Stimuli‐Responsive Peptides and Proteins
Qin et al. Mixed-charged zwitterionic polymeric micelles for tumor acidic environment responsive intracellular drug delivery
Zhang et al. Engineering anticancer amphipathic peptide-dendronized compounds for highly-efficient plasma/organelle membrane perturbation and multidrug resistance reversal
Jacoby et al. Order from disorder with intrinsically disordered peptide amphiphiles